NORMALIZATION OF HEMATOCRIT IN HEMODIALYSIS PATIENTS WITH CARDIAC DISEASE DOES NOT INCREASE BLOOD PRESSURE
- 1 January 2000
- journal article
- clinical trial
- Published by Taylor & Francis in Renal Failure
- Vol. 22 (4) , 435-444
- https://doi.org/10.1081/jdi-100100885
Abstract
Since the earliest reports of the use of Epoetin alfa in hemodialysis patients, it has been described that Epoetin alfa may exacerbate preexisting hypertension or induce hypertension in End Stage R...Keywords
This publication has 15 references indexed in Scilit:
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- Erythropoietin enhances vascular responsiveness to norepinephrine in renal failureKidney International, 1995
- Keynote Lecture: Erythropoietin and systemic hypertensionNephrology Dialysis Transplantation, 1995
- Pressor Effect of Recombinant Human Erythropoietin: Results of Ambulatory Blood Pressure Monitoring and Home Blood Pressure MeasurementsClinical and Experimental Hypertension, 1995
- Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietinThe American Journal of Medicine, 1993
- The use of recombinant human erythropoietin in end stage renal diseaseIrish Journal of Medical Science, 1993
- Effects of oxygen breathing and erythropoietin on hypoxic vasodilation in uremic anemiaKidney International, 1992
- Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy menJournal of Internal Medicine, 1991
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisThe American Journal of Medicine, 1990
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987